Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-445
Closed -$109K 722
2022
Q3
$109K Buy
+445
New +$120K ﹤0.01% 551
2021
Q4
Sell
-4,984
Closed -$1.62M 487
2021
Q3
$1.62M Buy
+4,984
New +$1.69M 0.05% 196
2021
Q2
Sell
-3,517
Closed -$1.12M 498
2021
Q1
$1.12M Buy
+3,517
New +$1.13M 0.03% 205

Other funds holding ABMD

Ossiam's ABMD Position: Q4 2022 in Review

Ossiam sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 445 shares — an estimated $109K sold.

Ossiam first reported a position in ABMD in Q1 2021 and held it in 3 quarters. The position peaked at $1.62M in Q3 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Ossiam reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Ossiam sold 445 Abiomed Inc shares in Q4 2022, an estimated $109K.
  • Ossiam first reported a position in Abiomed Inc in Q1 2021 and held it in 3 quarters.
  • Ossiam's Abiomed Inc position peaked at $1.62M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Ossiam's 13F filing for Q4 2022, filed 13 Feb 2023.